Literature DB >> 16357811

Factors associated with diabetic patients at high risk for foot ulceration.

F Leymarie1, J L Richard, D Malgrange.   

Abstract

In order to define risk factors for foot ulcers, associated with the major contributing factors (peripheral sensorimotor neuropathy, peripheral vascular disease, altered foot biomechanics and history of foot ulceration or lower limb amputation), a multivariate analysis was performed in 446 patients free from foot ulceration. Four significant risk factors for foot ulcers have been identified: retinopathy, poor psychosocial status, hyperkeratosis, and diabetes duration. A relation was present between the probability of belonging to the high-risk groups and the number of associated factors. This study points out to the importance of screening especially in case of diabetes of long duration, with microvascular complications, and in socially-deprived people.

Entities:  

Mesh:

Year:  2005        PMID: 16357811     DOI: 10.1016/s1262-3636(07)70238-0

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  4 in total

1.  Predicting development of proliferative diabetic retinopathy.

Authors:  Kristen Harris Nwanyanwu; Nidhi Talwar; Thomas W Gardner; James S Wrobel; William H Herman; Joshua D Stein
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

Review 2.  Growth factors for treating diabetic foot ulcers.

Authors:  Arturo J Martí-Carvajal; Christian Gluud; Susana Nicola; Daniel Simancas-Racines; Ludovic Reveiz; Patricio Oliva; Jorge Cedeño-Taborda
Journal:  Cochrane Database Syst Rev       Date:  2015-10-28

3.  Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review.

Authors:  Ian Pearce; Rafael Simó; Monica Lövestam-Adrian; David T Wong; Marc Evans
Journal:  Diabetes Obes Metab       Date:  2018-10-29       Impact factor: 6.577

4.  Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study.

Authors:  B Zantour; S Bouchareb; Z El Ati; F Boubaker; W Alaya; W Kossomtini; M H Sfar
Journal:  BMC Endocr Disord       Date:  2020-08-24       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.